NL:NYSENL Industries, Inc. Analysis
Data as of 2026-07-10 - not real-time
$6.07
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
NLI Holdings is trading just above its 20‑day moving average and comfortably beneath its 200‑day average, indicating a neutral technical stance with a slight upside bias. The RSI hovers around the 50‑mark, suggesting neither overbought nor oversold conditions, while the MACD histogram has turned positive, delivering a bullish signal despite a modest price gap. Volume is on the rise, supporting the technical optimism, yet the stock exhibits extremely high 30‑day volatility and a beta well below the market, underscoring pronounced price swings in a relatively defensive market environment. On the fundamentals side, the company offers an **exceptionally high dividend yield** that dwarfs the industry norm, but the payout ratio exceeds 100%, raising doubts about sustainability. Valuation metrics tell a mixed story: a forward P/E of roughly 7 versus an industry average above 30 points to a potential value opportunity, and the discounted cash‑flow model places fair value modestly above the current price, hinting at slight undervaluation. However, the firm reports a negative profit margin and a negative ROE, reflecting ongoing earnings challenges despite solid cash generation and a strong balance sheet with minimal debt.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD crossover with rising volume
- High short‑term volatility and proximity to support
- Dividend yield attractiveness offset by unsustainable payout
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value above current price suggesting upside
- Forward P/E dramatically lower than industry peers
- Improving cash flow and minimal leverage
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential for dividend policy normalization
- Value‑oriented valuation with room for price appreciation
- Diversified global footprint mitigating single‑market risk
Key Metrics & Analysis
Financial Health
Revenue Growth0.70%
Profit Margin-21.53%
P/E Ratio7.1
ROE-7.95%
ROA3.28%
Debt/Equity0.38
P/B Ratio0.8
Op. Cash Flow$7.5M
Free Cash Flow$15.5M
Industry P/E31.2
Technical Analysis
TrendNeutral
RSI49.4
Support$5.63
Resistance$6.35
MA 20$6.01
MA 50$6.25
MA 200$5.96
MACDBullish
VolumeIncreasing
Fear & Greed Index94.61
Valuation
Fair Value$6.33
GradeUndervalued
TypeValue
Dividend Yield6.56%
Risk Assessment
Beta0.75
Volatility82.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.